{"nctId":"NCT01436279","briefTitle":"Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks","startDateStruct":{"date":"2011-07"},"conditions":["Cervical Preparation"],"count":50,"armGroups":[{"label":"Mifepristone + misoprostol","type":"EXPERIMENTAL","interventionNames":["Drug: Mifepristone"]},{"label":"Osmotic dilators","type":"ACTIVE_COMPARATOR","interventionNames":["Device: osmotic dilators"]}],"interventions":[{"name":"Mifepristone","otherNames":["Mifeprex","RU-486","Mifegyne"]},{"name":"osmotic dilators","otherNames":["Laminaria","Dilapan-S","Dilapan"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Women 18-50 years of age undergoing surgical termination of pregnancy\n* English or Spanish speaking\n* Gestational age between 15 and 18 weeks gestation on day of abortion (inclusive), by ultrasound dating\n* Eligible for a dilation and evacuation abortion with local anesthesia and sedation\n* Ultrasound for dating purposes done within the last two weeks\n\nExclusion Criteria:\n\n* Intrauterine infection\n* Fetal demise\n* Ruptured membranes\n* Multiple gestation\n* Uterine anomaly or significant distortion of the uterus with fibroids\n* BMI greater than 45\n* Inability to place osmotic dilators\n* Active substance abuse or intoxication\n* Adrenal failure, chronic corticosteroid use, anticoagulant usage\n* Severe cervicitis, until treated and resolved\n* Prior Cesarean section","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"50 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Length of Procedure","description":"Interval from speculum insertion to speculum removal","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"13.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Operative Time","description":"Interval from initiation of vacuum aspiration to speculum removal","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"8.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Subject Discomfort Before the Abortion","description":"Pain was subjectively described by the subjects as : None, Mild, Moderate, Severe","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Pain Medication (Fentanyl) During the Abortion","description":"Amount of pain medication used during the procedure: reported as micrograms of fentanyl","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.1","spread":"1.34"},{"groupId":"OG001","value":"2.9","spread":"1"}]}]}]},{"type":"SECONDARY","title":"Pain Medication (Midazolam) During the Abortion","description":"Amount of pain medication used during the procedure: reported as milligrams of midazolam","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"104","spread":"31"},{"groupId":"OG001","value":"105","spread":"26"}]}]}]},{"type":"SECONDARY","title":"Cervical Dilation Achieved","description":"Cervical dilation at start of procedure","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":"11"},{"groupId":"OG001","value":"56","spread":"5"}]}]}]},{"type":"SECONDARY","title":"Acceptability to Patient","description":"Patient was asked whether they would choose to be in the same group again if they had a similar procedure again. The number of participants whose response was \"yes\" is being reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"SECONDARY","title":"Difficulty of Procedure","description":"Outcome measure is the number and percentage of participants where the provider rated the procedure as \"difficult or very difficult\". Provider assessment of difficulty of procedure categories were: \"very easy\", \"easy\", \"moderate\", \"difficult\", or \"very difficult.\"","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":[]}}}